Anne Rose, PharmD, on Low- vs High-Dose Anticoagulation Therapy and Risk-Stratifying Patients
In this podcast, Anne Rose, PharmD, talks about her session at the Anticoagulation Forum 2021, during which she highlighted the\xa0factors associated with increased risk of recurrent VTE,\xa0appropriate duration of anticoagulation for VTE depending on risk/benefit analysis, and\xa0extended anticoagulation. More at: www.consultant360.com